- Home
- Equipment
- asia middle east
- drug release system
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Drug Release System Equipment Supplied In Asia Middle East
4 equipment items found
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
Conversion of Sirolimus drug into sub-micron sized particles; Nanocarriers created by encapsulation of sub-micron sized Sirolimus drug into highly biocompatible drug Carrier-phospholipid; Encapsulated Sirolimus is coated on stent and parts of balloon; Upon implantation of Abluminus NP at target site, Nanocarriers with Sirolimus drug from stent and parts of balloon get transferred to the vessel ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
BioMatrix™ Alpha presents the best in class stent platform design with unique pro-healing coating from the pioneer in abluminal biodegradable technology. It combines the proven safety of a DES with an abluminal biodegradable polymer, the proven efficacy of BA9™ and an innovative cobalt-chromium stent platform ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
Drug is coated on the abluminal side only. Leading to mono directional drug release & less systemic exposure of drug which leads to faster ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction. ...